In addition, HSP70/90 can form an HSP-peptide complex with a tumor-specific antigen peptide, which can present tumor antigens to MHC-I molecules on the DC surface and induce a tumor-specific immune response [29]. This evidence concerns the gene HSP90B2P and neoplasm.